1. Home
  2. Research
  3. Research Groups
  4. Multiple Sclerosis

Multiple Sclerosis

Search for publications

Only original articles, editorials, guidelines.

  • Camacho-Toledano C, Machín-Díaz I, Calahorra L, Cabañas-Cotillas M, Otaegui D, Castillo-Triviño T, Villar LM, Costa-Frossard L, Comabella M, Midaglia L, García-Domínguez JM, García-Arocha J, Ortega MC, Clemente D.

    Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis

    JOURNAL OF NEUROINFLAMMATION . 19(1): 277-277. Number of citations: 3

    [doi:10.1186/s12974-022-02635-3]

  • Cogram P, Fernández-Beltrán LC, Casarejos MJ, Sánchez-Yepes S, Rodríguez-Martín E, García-Rubia A, Sánchez-Barrena MJ, Gil C, Martínez A, Mansilla A.

    The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes.

    FRONTIERS IN NEUROSCIENCE . 16: 1007531-1007531.

    [doi:10.3389/fnins.2022.1007531]

  • Domínguez-Mozo MI, García-Frontini Nieto MC, Gómez-Calcerrada MI, Pérez-Pérez S, García-Martínez MÁ, Villar LM, Villarrubia N, Costa-Frossard L, Arroyo R, Alvarez-Lafuente R.

    Mitochondrial Impairments in Peripheral Blood Mononuclear Cells of Multiple Sclerosis Patients.

    BIOLOGY-BASEL . 11(11): .

    [doi:10.3390/biology11111633]

  • Baena-Álvarez B, Rodríguez-Jorge F, Beltrán-Corbellini Á, Cortés-Salgado A, De la Puente C, Corral Í.

    Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma.

    JOURNAL OF NEUROVIROLOGY . 29(1): 116-119.

    [doi:10.1007/s13365-022-01103-1]

  • Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA.

    Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials.

    JOURNAL OF IMMUNOLOGICAL METHODS . 510: 113344-113344.

    [doi:10.1016/j.jim.2022.113344]

  • Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Plata M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain.

    Neurologia . 37(8): 615-630. Number of citations: 1

    [doi:10.1016/j.nrleng.2019.11.001]

  • Meca-Lallana JE, Fernández-Prada M, García Vázquez E, Moreno Guillén S, Otero Romero S, Rus Hidalgo M, Villar Guimerans LM, Eichau Madueño S, Fernández Fernández Ó, Izquierdo Ayuso G, Álvarez Cermeño JC, Arnal García C, Arroyo González R, Brieva Ruiz L, Calles Hernández C, García Merino A, González Platas M, Hernández Pérez MÁ, Moral Torres E, Olascoaga Urtaza J, Oliva-Nacarino P, Oreja-Guevara C, Ortiz Castillo R, Oterino A, Prieto González JM, Ramió-Torrentá L, Rodríguez-Antigüedad A, Saiz A, Tintoré M, Montalbán Gairin X.

    Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    NEUROLOGIA . 37(8): 615-630. Number of citations: 2

    [doi:10.1016/j.nrl.2019.11.003]

  • Meca-Lallana JE, Gómez-Ballesteros R, Pérez-Miralles F, Forero L, Sepúlveda M, Calles C, Martínez-Ginés ML, González-Suárez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Prefasi D, Maurino J.

    Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients' Perspective: An Observational Cross-Sectional Study

    Neurology and Therapy . 11(3): 1101-1116. Number of citations: 2

    [doi:10.1007/s40120-022-00356-6]

  • Cobeta P, Pariente R, Osorio A, Marchan M, Cuadrado-Ayuso M, Pestaña D, Galindo J, Botella-Carretero JI.

    The Role of Adiponectin in the Resolution of Male-Obesity-Associated Secondary Hypogonadism after Metabolic Surgery and Its Impact on Cardiovascular Risk.

    Biomedicines . 10(8): . Number of citations: 1

    [doi:10.3390/biomedicines10082000]

  • Labiano-Fontcuberta A, Costa-Frossard L, Sainz de la Maza S, Rodríguez-Jorge F, Chico-García JL, Monreal E.

    The effect of timing of high-efficacy therapy on processing speed performance in multiple sclerosis

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 64: 103959-103959. Number of citations: 3

    [doi:10.1016/j.msard.2022.103959]

  • Castillo-Triviño T, Gómez-Ballesteros R, Borges M, Martín-Martínez J, Sotoca J, Alonso A, Caminero AB, Borrega L, Sánchez-Menoyo JL, Barrero-Hernández FJ, Calles C, Brieva L, Blasco-Quílez MR, García-Soto JD, Del Campo-Amigo M, Navarro-Cantó L, Agüera E, Garcés-Redondo M, Carmona O, Gabaldón-Torres L, Forero L, Hervás M, Mauriño J, Sainz de la Maza S.

    Long-term prognosis communication preferences in early-stage relapsing-remitting multiple sclerosis

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 64: 103969-103969. Number of citations: 1

    [doi:10.1016/j.msard.2022.103969]

  • Meca-Lallana JE, Casanova B, Rodríguez-Antigüedad A, Eichau S, Izquierdo G, Durán C, Río J, Hernández MÁ, Calles C, Prieto-González JM, Ara JR, Uría DF, Costa-Frossard L, García-Merino A, Oreja-Guevara C.

    Consensus on early detection of disease progression in patients with multiple sclerosis

    Frontiers in Neurology . 13: 931014-931014.

    [doi:10.3389/fneur.2022.931014]

  • Alcina A, Fedetz M, Vidal-Cobo I, Andrés-León E, García-Sánchez MI, Barroso-Del-Jesus A, Eichau S, Gil-Varea E, Villar LM, Saiz A, Leyva L, Vandenbroeck K, Otaegui D, Izquierdo G, Comabella M, Urcelay E, Matesanz F.

    Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis

    HUMAN MOLECULAR GENETICS . 31(13): 2155-2163. Number of citations: 4

    [doi:10.1093/hmg/ddac009]

  • Brieva L, Estruch BC, Merino JAG, Meca-Lallana V, Río J, Rodríguez-Antigüedad A, Agüera E, Ara JR, Luque AA, Garcia CA, Blanco Y, Castillo-Triviño T, Costa-Frossard L, González Platas M, Pascual LL, Llaneza-González M, Ginés MLM, Matías-Guiu J, Meca-Lallana JE, Bilbao MM, Sempere AP, Romero-Pinel L, Saiz A, Moral E.

    Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 63: 103805-103805. Number of citations: 1

    [doi:10.1016/j.msard.2022.103805]

  • Lopez-Soley E, Meca-Lallana JE, Llufriu S, Blanco Y, Gómez-Ballesteros R, Maurino J, Pérez-Miralles F, Forero L, Calles C, Martinez-Gines ML, Gonzalez-Suarez I, Boyero S, Romero-Pinel L, Sempere ÁP, Meca-Lallana V, Querol L, Costa-Frossard L, Sepulveda M, Solana E.

    Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder

    Journal of Personalized Medicine . 12(5): . Number of citations: 4

    [doi:10.3390/jpm12050743]

  • Matute-Blanch C, Brito V, Midaglia L, Villar LM, Garcia-Diaz Barriga G, Guzman de la Fuente A, Borrás E, Fernández-García S, Calvo-Barreiro L, Miguez A, Costa-Frossard L, Pinteac R, Sabidó E, Alberch J, Fitzgerald DC, Montalban X, Comabella M.

    Inflammation in multiple sclerosis induces a specific reactive astrocyte state driving non-cell-autonomous neuronal damage

    Clinical And Translational Medicine . 12(5): . Number of citations: 3

    [doi:10.1002/ctm2.837]

  • Sáez-Landete I, Gómez-Domínguez A, Estrella-León B, Díaz-Cid A, Fedirchyk O, Escribano-Muñoz M, Pedrera-Mazarro A, Martín-Palomeque G, Garcia-Ribas G, Rodríguez-Jorge F, Santos-Pérez G, Lourido-García D, Regidor-BaillyBailliere I.

    Retrospective Analysis of EEG in Patients With COVID-19: EEG Recording in Acute and Follow-up Phases.

    CLINICAL EEG AND NEUROSCIENCE . 53(3): 215-228. Number of citations: 5

    [doi:10.1177/15500594211035923]

  • Fernández-Velasco JI, Monreal E, Kuhle J, Meca-Lallana V, Meca-Lallana J, Izquierdo G, Oreja-Guevara C, Gascón-Giménez F, Sainz de la Maza S, Walo-Delgado PE, Lapuente-Suanzes P, Maceski A, Rodríguez-Martín E, Roldán E, Villarrubia N, Saiz A, Blanco Y, Diaz-Pérez C, Valero-López G, Diaz-Diaz J, Aladro Y, Brieva L, Íñiguez C, González-Suárez I, Rodríguez de Antonio LA, García-Domínguez JM, Sabin J, Llufriu S, Masjuan J, Costa-Frossard L, Villar LM.

    Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.

    Frontiers in immunology . 13: 842354-842354.

    [doi:10.3389/fimmu.2022.842354]